Taztia XT Capsules (Shamrock) – Label Mix-up (2011)
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death
Class I recall indicates potential for serious health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90
Brand
Shamrock Medical Solutions Group LLC
Lot Codes / Batch Numbers
Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90
Products Sold
Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90
Shamrock Medical Solutions Group LLC is recalling Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: S due to Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CO, MA, OH, TX, WY
Page updated: Jan 7, 2026